Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 16,406 shares at $44.59 ($730K) on 2024-09-11, disclosed to the SEC on 2024-09-13.
Open-market sale of $730k PTGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.47 | 12,000 | $534K | 73.1% |
| 2 | $44.59 | 2,203 | $98K | 13.5% |
| 3 | $44.59 | 2,203 | $98K | 13.5% |
| Total | $44.50 avg | 16,406 | $730K | 100% |
| Filing → |
| PTGX | SELL | 2026-03-27 | $2.6M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $3.8M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |